{"id":347,"date":"2023-04-25T17:52:06","date_gmt":"2023-04-25T17:52:06","guid":{"rendered":"https:\/\/eastmedia.lt\/nuotolinio-pacientu-stebejimo-platforma-neteera-surinko-apie-13-mln\/"},"modified":"2023-04-25T17:52:06","modified_gmt":"2023-04-25T17:52:06","slug":"nuotolinio-pacientu-stebejimo-platforma-neteera-surinko-apie-13-mln","status":"publish","type":"post","link":"https:\/\/easa.lt\/index.php\/2023\/04\/25\/nuotolinio-pacientu-stebejimo-platforma-neteera-surinko-apie-13-mln\/","title":{"rendered":"Nuotolinio pacient\u0173 steb\u0117jimo platforma \u201eNeteera\u201c surinko apie 13 mln"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.mobihealthnews.com\/sites\/default\/files\/web_16x9_lg-694983381_0.JPG\" \/><\/p>\n<div property=\"content:encoded\">\n<p dir=\"ltr\"><span id=\"docs-internal-guid-4cb27a4e-7fff-b304-5689-35680ac71521\">Izraelyje \u012fsik\u016brusi \u201eNeteera\u201c, si\u016blanti bekontakt\u012f nuotolin\u012f pacient\u0173 steb\u0117jim\u0105, paskelb\u0117 u\u017ebaigusi B serijos finansavimo etap\u0105, kurio vert\u0117 apie 13 mln.<\/span><\/p>\n<p dir=\"ltr\"><span id=\"docs-internal-guid-4cb27a4e-7fff-b304-5689-35680ac71521\">\u201eAescuvest\u201c pirmavo kartu su esamais ir naujais investuotojais \u201eNanz Family Office\u201c, \u201eOmega Healthcare Investors\u201c, \u201eEsas Private Equity\u201c ir \u201eAnkor Holding\u201c.<\/span><\/p>\n<p dir=\"ltr\"><span id=\"docs-internal-guid-4cb27a4e-7fff-b304-5689-35680ac71521\">Bendrov\u0117 taip pat paskelb\u0117 apie savo strategin\u0119 partneryst\u0119 su \u201eOmega\u201c, kuri teikia <\/span>technologijomis pagr\u012fstos pajam\u0173 ciklo valdymo ir klinikin\u0117s komunikacijos paslaugos.  \u201eOmega\u201c si\u016blys \u201eNeteera\u201c platform\u0105 savo ilgalaikei prie\u017ei\u016brai ir kvalifikuotoms slaugos \u012fstaigoms JAV<\/p>\n<p dir=\"ltr\"><strong><span id=\"docs-internal-guid-4cb27a4e-7fff-b304-5689-35680ac71521\">K\u0104 TAI DARO<\/span><\/strong><\/p>\n<p dir=\"ltr\"><span id=\"docs-internal-guid-4cb27a4e-7fff-b304-5689-35680ac71521\">\u201eNeteera\u201c si\u016blo bekontakt\u012f pacient\u0173 steb\u0117jimo \u012frengin\u012f, kuris naudoja radaro technologij\u0105, kad gal\u0117t\u0173 sekti gyvybines funkcijas, \u012fskaitant \u0161irdies ir kv\u0117pavimo da\u017en\u012f, kv\u0117pavimo gyl\u012f, \u0161irdies ritmo kintamum\u0105, \u012fkv\u0117pimo\/i\u0161kv\u0117pimo santyk\u012f ir kt.  Radaras ap\u010diuopia mikroskopinius odos judesius net per paciento drabu\u017eius, kad surinkt\u0173 informacij\u0105 apie paciento gyvybinius po\u017eymius. <\/span><\/p>\n<p dir=\"ltr\"><span id=\"docs-internal-guid-4cb27a4e-7fff-b304-5689-35680ac71521\">Bendrov\u0117 panaudos l\u0117\u0161as, kad paspartint\u0173 pacient\u0173 steb\u0117jimo sprendimo k\u016brim\u0105, pardavim\u0105 ir diegim\u0105 bei toliau pl\u0117tot\u0173 savo medicininio jutimo platform\u0105. <\/span><\/p>\n<p dir=\"ltr\"><span id=\"docs-internal-guid-4cb27a4e-7fff-b304-5689-35680ac71521\">\u201eAescuvest yra \u012fsipareigojusi finansuoti sveikatos prie\u017ei\u016bros pl\u0117tr\u0105, kuri daro teigiam\u0105 poveik\u012f visuomenei, ir mes tikime, kad naujovi\u0161ka Neteera technologija gali pakeisti pacient\u0173 steb\u0117jimo ir prie\u017ei\u016bros b\u016bdus\u201c, \u2013 sak\u0117 \u201eAescuvest\u201c partneris ir investicij\u0173 vadovas Sebastianas G\u00fchrsas. parei\u0161kime. <\/span><\/p>\n<p dir=\"ltr\"><strong><span id=\"docs-internal-guid-4cb27a4e-7fff-b304-5689-35680ac71521\">RINKOS momentinis vaizdas<\/span><\/strong><\/p>\n<p dir=\"ltr\"><span id=\"docs-internal-guid-4cb27a4e-7fff-b304-5689-35680ac71521\">Neteera gavo <\/span>Rugs\u0117jo m\u0117n. FDA 510(k) patvirtino savo \u0161irdies steb\u0117jimo prietais\u0105. <\/p>\n<p dir=\"ltr\"><span id=\"docs-internal-guid-4cb27a4e-7fff-b304-5689-35680ac71521\">Galimyb\u0117 steb\u0117ti pacient\u0173 sveikat\u0105 nuotoliniu b\u016bdu tapo <\/span>vis labiau populiar\u0117ja, nors ekspertai teigia, kad svarbu rinktis lengvai naudojamus \u012frenginius, kuriems pacientams nereikia papildom\u0173 technologij\u0173.  <\/p>\n<p dir=\"ltr\"><span id=\"docs-internal-guid-4cb27a4e-7fff-b304-5689-35680ac71521\">\u012emon\u0117s u\u017emezg\u0117 partnerystes, siekdamos i\u0161pl\u0117sti nuotolinio pacient\u0173 steb\u0117jimo erdv\u0119, \u012fskaitant <\/span>medicinos technologij\u0173 \u012fmon\u0117s \u201ePhilips\u201c ir \u201eMasimo\u201c, kurios paskelb\u0117 apie bendradarbiavim\u0105, leid\u017eiant\u012f W1 laikrod\u017eio gyvybi\u0161kai svarbius duomenis si\u0173sti \u012f \u201ePhilips\u201c pacient\u0173 steb\u0117jimo ekosistem\u0105. <\/p>\n<p dir=\"ltr\"><span id=\"docs-internal-guid-4cb27a4e-7fff-b304-5689-35680ac71521\">\u201eGE Healthcare\u201c ir \u201eAMC Health\u201c.<\/span> taip pat bendradarbiavo, kad pasi\u016blyt\u0173 nuotolinio pacient\u0173 steb\u0117jimo technologij\u0105 pacientams po to, kai jie buvo i\u0161ra\u0161yti i\u0161 ligonin\u0117s. <\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Izraelyje \u012fsik\u016brusi \u201eNeteera\u201c, si\u016blanti bekontakt\u012f nuotolin\u012f pacient\u0173 steb\u0117jim\u0105, paskelb\u0117 u\u017ebaigusi B serijos finansavimo etap\u0105, kurio vert\u0117 apie 13 mln. \u201eAescuvest\u201c pirmavo kartu su esamais ir naujais investuotojais \u201eNanz Family Office\u201c, \u201eOmega Healthcare Investors\u201c, \u201eEsas Private Equity\u201c ir \u201eAnkor Holding\u201c. Bendrov\u0117 taip pat paskelb\u0117 apie savo strategin\u0119 partneryst\u0119 su \u201eOmega\u201c, kuri teikia technologijomis pagr\u012fstos pajam\u0173 ciklo [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":348,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-347","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-bendri"],"_links":{"self":[{"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/posts\/347","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/comments?post=347"}],"version-history":[{"count":0,"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/posts\/347\/revisions"}],"wp:attachment":[{"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/media?parent=347"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/categories?post=347"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/easa.lt\/index.php\/wp-json\/wp\/v2\/tags?post=347"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}